PFS Partners, LLC
Follow13F filer, CIK 2002654, MINE HILL, NJ
PFS Partners, LLC reported $198,541,026 across 506 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-07-16. Its ten largest share positions make up 61.05% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002002654-25-000004
- Period
- 2025-06-30
- Reported value
- $199M
- Holdings
- 506
- Top 10 weight
- 61.05%
- New
- 87
- Sold out
- 21
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| JAAAadded | +27,945 | $1.42M |
| KJUNadded | +17,230 | $445K |
| AAPLadded | +1,713 | $351K |
| FPEadded | +13,988 | $249K |
| Vadded | +600 | $213K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| FSMBreduced | -33,820 | -$673K |
| LMBSreduced | -5,402 | -$266K |
| KJANreduced | -5,726 | -$215K |
| HEIreduced | -537 | -$176K |
| KDECexited | -5,976 | -$137K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2025
Share positions as resolved from 13F-HR 0002002654-25-000004, largest first. % of portfolio is the value over $198,498,907, the sum of the share positions whose value is usable for ratios (method).
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| TRVITREVI THERAPEUTICS INC Stock | call | 7,700 | $42.1K | new |
Sold out in Q2 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| AIGAMERICAN INTL GROUP INC | 10,000 | $869K | put |
| MUMICRON TECHNOLOGY INC | 3,900 | $339K | put |
| KDECINNOVATOR ETFS TRUST | 5,976 | $137K | shares |
| INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC | 300 | $39.6K | shares |
| APLDAPPLIED DIGITAL CORP | 4,267 | $24K | shares |
| KULR TECHNOLOGY GROUP INCKULR TECHNOLOGY GROUP INC | 15,644 | $20.7K | shares |
| ORGANIGRAM HLDGS INCORGANIGRAM HLDGS INC | 19,000 | $19.2K | shares |
| PFMINVESCO EXCHANGE TRADED FD T | 238 | $10.9K | shares |
| MSGSMADISON SQUARE GRDN SPRT COR | 50 | $9.74K | shares |
| HUNHUNTSMAN CORP | 328 | $5.18K | shares |
| ETF SER SOLUTIONSETF SER SOLUTIONS | 205 | $4.71K | shares |
| RCREADY CAPITAL CORP | 777 | $3.96K | shares |
| PTHINVESCO EXCHANGE TRADED FD T | 87 | $3.44K | shares |
| URBAN-GRO INCURBAN-GRO INC | 7,000 | $2.83K | shares |
| CRLCHARLES RIV LABS INTL INC | 14 | $2.11K | shares |
| UNITED STATES STL CORP NEWUNITED STATES STL CORP NEW | 33 | $1.39K | shares |
| NBISNEBIUS GROUP N.V. | 60 | $1.27K | shares |
| SRESEMPRA | 15 | $1.07K | shares |
| ATYRATYR PHARMA INC | 340 | $1.03K | shares |
| 2SEVENTY BIO INC COMMON STO…2SEVENTY BIO INC COMMON STOCK | 113 | $559 | shares |
| GOSSGOSSAMER BIO INC | 50 | $55 | shares |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002002654-25-000004 | base | 2025-07-16 | acceptance time not in the bulk data set |